KRAS Mutation in Patients with Lung Cancer: A Predictor for Poor Prognosis but Not for EGFR-TKIs or Chemotherapy
作者： Ji-lin Guan , Wen-zhao Zhong , She-juan An , Jin-ji Yang , Jian Su
DOI: 10.1245/S10434-012-2754-Z
关键词:
摘要: … is a factor indicating poor prognosis in lung cancer, but it has limited value in predicting chemotherapy and EGFR-TKI responses. Moreover, an EGFR mutation should not only be …
springer.com
sci-hub.se 参考文章(35)
M.I. Gallegos-Ruiz, P.E. Postmus, D. Kramer, C.J.L.M. Meijer, E.F. Smit, P.J.F. Snijders, F.B.J.M. Thunnissen, D.A.M. Heideman, A fast, sensitive and accurate high resolution melting (HRM) technology-based assay to screen for common K-ras mutations. Analytical Cellular Pathology. ,vol. 31, pp. 161- 167 ,(2009) , 10.3233/CLO-2009-0466
C Mascaux, N Iannino, B Martin, M Paesmans, T Berghmans, M Dusart, A Haller, P Lothaire, A-P Meert, S Noel, J-J Lafitte, J-P Sculier, The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis British Journal of Cancer. ,vol. 92, pp. 131- 139 ,(2005) , 10.1038/SJ.BJC.6602258
Tetsukan Woo, Koji Okudela, Takuya Yazawa, Nobuyuki Wada, Nobuo Ogawa, Naoki Ishiwa, Michihiko Tajiri, Yasushi Rino, Hitoshi Kitamura, Munetaka Masuda, Prognostic value of KRAS mutations and Ki-67 expression in stage I lung adenocarcinomas Lung Cancer. ,vol. 65, pp. 355- 362 ,(2009) , 10.1016/J.LUNGCAN.2008.11.020
F Grossi, M Loprevite, M Chiaramondia, P Ceppa, C Pera, G.B Ratto, J Serrano, G.B Ferrara, R Costa, L Boni, A Ardizzoni, Prognostic significance of K-ras, p53, bcl-2, PCNA, CD34 in radically resected non-small cell lung cancers. European Journal of Cancer. ,vol. 39, pp. 1242- 1250 ,(2003) , 10.1016/S0959-8049(03)00232-6
Chen Mao, Li-Xin Qiu, Ru-Yan Liao, Fang-Bing Du, Hong Ding, Wan-Chun Yang, Jin Li, Qing Chen, None, KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: A meta-analysis of 22 studies Lung Cancer. ,vol. 69, pp. 272- 278 ,(2010) , 10.1016/J.LUNGCAN.2009.11.020
Carlos Camps, Eloisa Jantus-Lewintre, Andrea Cabrera, Ana Blasco, Elena Sanmartín, Sandra Gallach, Cristina Caballero, Nieves del Pozo, Rafael Rosell, Ricardo Guijarro, Rafael Sirera, The identification of KRAS mutations at codon 12 in plasma DNA is not a prognostic factor in advanced non-small cell lung cancer patients. Lung Cancer. ,vol. 72, pp. 365- 369 ,(2011) , 10.1016/J.LUNGCAN.2010.09.005
Makoto Sonobe, Masashi Kobayashi, Masashi Ishikawa, Ryutaro Kikuchi, Ei Nakayama, Tsuyoshi Takahashi, Toshi Menju, Kazumasa Takenaka, Ryo Miyahara, Cheng-Long Huang, Kenichi Okubo, Toru Bando, Hiroshi Date, Impact of KRAS and EGFR Gene Mutations on Recurrence and Survival in Patients with Surgically Resected Lung Adenocarcinomas Annals of Surgical Oncology. ,vol. 19, pp. 347- 354 ,(2012) , 10.1245/S10434-011-1799-8
G. J. Riely, J. Marks, W. Pao, KRAS mutations in non-small cell lung cancer. Proceedings of the American Thoracic Society. ,vol. 6, pp. 201- 205 ,(2009) , 10.1513/PATS.200809-107LC
Sarit Aviel-Ronen, Fiona H. Blackhall, Frances A. Shepherd, Ming-Sound Tsao, K-ras Mutations in Non-Small-Cell Lung Carcinoma: A Review Clinical Lung Cancer. ,vol. 8, pp. 30- 38 ,(2006) , 10.3816/CLC.2006.N.030
Petra Broermann, Klaus Junker, Burkhard H. Brandt, Achim Heinecke, Lutz Freitag, Folker Klinke, Wolfgang E. Berdel, Michael Thomas, Trimodality Treatment in Stage III Nonsmall Cell Lung Carcinoma Prognostic Impact of K-ras Mutations after Neoadjuvant Therapy Cancer. ,vol. 94, pp. 2055- 2062 ,(2002) , 10.1002/CNCR.10387